Artiva Biotherapeutics, Inc.·4

Sep 13, 4:15 PM ET

Krishnamohan Neha 4

4 · Artiva Biotherapeutics, Inc. · Filed Sep 13, 2024

Insider Transaction Report

Form 4
Period: 2024-09-12
Krishnamohan Neha
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2024-09-12+50,00050,000 total
Footnotes (1)
  • [F1]Represents restricted stock unit award granted under the Issuer's 2024 Equity Incentive Plan.

Documents

1 file
  • 4
    form4-09132024_040906.xmlPrimary